ORDER INFORMATION
Would you like to talk about a product? Please contact us at 866.712.0881
TENS 3000
Key Features
- 3 TENS Modes: Burst, Modulation, Constant
- Pulse Width: 30-260 (uS)
- Pulse Rate: 20-150(Hz)
- 80 mA Amplitude
- Dual Channels
- Wave Form: Asymmetrical Bi-Phasic Square Pulse
- Timer: 15, 30, Constant
Description
Roscoe Medical TENS 3000
“TENS” stands for transcutaneous electric nerve stimulation. The TENS unit sends comfortable impulses through the skin that stimulate the nerve (or nerves) in the treatment area. In many cases, this stimulation will greatly reduce or eliminate pain. In many patients, the reduction or elimination of pain lasts longer than the actual period of stimulation (sometimes as much as three to four times longer).
TENS 3000
- Delivers non-addictive and non-invasive analgesia via the disruption of pain signals across sensory nerves
- Facilitates simple, self-administered treatments via the portable unit (approximately the size of a deck of playing cards)
- Carries a favorable benefit-to-risk ratio because it has no notable adverse effects and no interactions with other treatments
- Utilizes a standard 9-volt battery and adhesive electrodes
Safe & Effective
Hundreds of patients and clinical reports support the efficacy of the TENS 3000, not just because it works, but because it is free of the functional impairment associated with narcotic analgesics that may adversely affect a patient.
Typical Indications
Symptomatic relief and management of chronic (long-term), intractable pain and an adjunctive treatment in the management of post-surgical pain or post-traumatic acute pain.
- A 2005 study showed that TENS has efficacy in the acute phase of severe low back injury, yielding statistically significant reductions in pain - proving to be a rapid, safe, noninvasive, non-drug-based, well-tolerated, easily administered analgesic (Acad. Emer. Med.; 12:607).
- Another 2005 study found TENS to be a “useful therapy for the short-term relief of chronic low back pain” with pain scores dropping by 50%. The authors conclude that TENS should be considered where short-term pain relief is desired (J of Musculoskel Pain; 13(2):11).
- A statistically robust TENS clinical trial, published in 2012 with 236 participants found highly significant reductions in pain intensity (P= 0.0003) with TENS treatment. Four times as many patients in the active TENS group reported a 50% or greater reduction in their chronic lumbar pain (Eur J of Pain 2012;16:656).
